News and Views
Nature Medicine 14, 1148 - 1150 (2008)
doi:10.1038/nm1108-1148
Epstein-Barr virus sustains tumor killers
Richard J O'Reilly1
-
Richard J. O'Reilly is at the Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10021, USA.
e-mail: oreillyr@mskcc.org
Abstract
The immune system's response to a latent and ubiquitous virus is harnessed to kill tumors in a small study of humans. The approach overcomes a major barrier to effective tumor immunotherapy—generating a sustained immune response (pages 1264–1270).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Identification of IGFBP-6 as an effector of the tumor suppressor activity of SEMA3BOncogene Original Article
Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastomaNature Medicine Article (01 Nov 2008)
